G4S/ADR (OTCMKTS:GFSZY) Upgraded at ValuEngine

Share on StockTwits

ValuEngine upgraded shares of G4S/ADR (OTCMKTS:GFSZY) from a sell rating to a hold rating in a report released on Monday, September 17th.

A number of other equities analysts have also recently weighed in on the stock. Zacks Investment Research raised shares of G4S/ADR from a sell rating to a hold rating in a research report on Friday, September 7th. Kepler Capital Markets assumed coverage on shares of G4S/ADR in a research report on Tuesday, May 22nd. They set a buy rating for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of Buy and an average target price of $20.00.

Shares of OTCMKTS:GFSZY traded up $0.01 during mid-day trading on Monday, reaching $14.40. 34,126 shares of the company were exchanged, compared to its average volume of 14,853. The company has a debt-to-equity ratio of 1.84, a quick ratio of 1.02 and a current ratio of 1.06. The stock has a market capitalization of $4.88 billion, a P/E ratio of 12.52, a PEG ratio of 1.17 and a beta of 1.17. G4S/ADR has a 1 year low of $14.21 and a 1 year high of $20.83.

G4S/ADR Company Profile

G4S plc, together with its subsidiaries, engages in the provision of security and related services in the United Kingdom, Ireland, Africa, the Asia Pacific, the Middle East, India, Latin America, Europe, and North America. The company offers integrated solutions, including analytics and intelligence, technology and software, consulting and risk management, monitoring and response, and manned and mobile security, as well as systems design, built, and integration services.

See Also: What is insider trading?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for G4S/ADR (OTCMKTS:GFSZY)

Receive News & Ratings for G4S/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for G4S/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.